According to Latest Study, the global market for Dermal Fillers and Botulinum Toxin should grow from US$ 13080 million in 2022 to US$ 26330 million by 2029, with a CAGR of 10.3% for the period of 2023-2029.

Global key players of dermal fillers and botulinum toxin include AbbVie, Galderma, LG Life Sciences, etc. The top three players hold a share about 72%. Americas is the largest market, has a share about 58%, followed by Europe and Asia-Pacific, with share 21% and 18%, separately.

Dermal fillers help to diminish facial lines and restore volume and fullness in the face. Dermal fillers can be used to: plump thin lips, enhance shallow contours, soften facial creases and wrinkles and improve the appearance of recessed scars. Dermal fillers can be very helpful in those with early signs of aging, or as a value-added part of facial rejuvenation surgery. Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research.

This report aims to provide a comprehensive study of the global market for Dermal Fillers and Botulinum Toxin. Report Highlights:

(1) Global Dermal Fillers and Botulinum Toxin market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Dermal Fillers and Botulinum Toxin market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(3) China Dermal Fillers and Botulinum Toxin market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(4) Global Dermal Fillers and Botulinum Toxin segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Dermal Fillers and Botulinum Toxin segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Dermal Fillers and Botulinum Toxin, capacity, production and trends.

(7) Dermal Fillers and Botulinum Toxin industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Dermal Fillers

Botulinum Toxin

Market segment by application, can be divided into

Cosmetic

Medical

Market segment by players, this report covers

AbbVie

Galderma

LG Life Sciences

Merz

Medytox

Hugel

Croma-Pharma

Beijing IMEIK

Bloomage Bio

Elravie (Humedix)

Cleviel (Pharma Research Products)

Haohai Biological

Teoxane

Sinclair

Suneva Medical

CG Bio

SciVision Biotech

Prollenium

Bohus BioTech

Caregen

Ipsen

LIBP

US World Meds

Daewoong

JETEMA

1 Market Overview

1.1 Dermal Fillers and Botulinum Toxin Definition

1.2 Global Dermal Fillers and Botulinum Toxin Market Size and Forecast

1.2.1 By Revenue, Global Dermal Fillers and Botulinum Toxin Market Size, 2018-2029

1.2.2 By Sales Volume, Global Dermal Fillers and Botulinum Toxin Market Size, 2018-2029

1.2.3 Global Dermal Fillers and Botulinum Toxin Price Trend, 2018-2029

1.3 China Dermal Fillers and Botulinum Toxin Market Size and Forecast

1.3.1 By Revenue, China Dermal Fillers and Botulinum Toxin Market Size, 2018-2029

1.3.2 By Sales Volume, China Dermal Fillers and Botulinum Toxin Market Size, 2018-2029

1.3.3 China Dermal Fillers and Botulinum Toxin Price Trend, 2018-2029

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Dermal Fillers and Botulinum Toxin Share in Global Market, 2018-2029

1.4.2 By Sales Volume, China Dermal Fillers and Botulinum Toxin Share in Global Market, 2018-2029

1.4.3 Dermal Fillers and Botulinum Toxin Market Size: China VS Global, 2018-2029

1.5 Dermal Fillers and Botulinum Toxin Market Dynamics

1.5.1 Dermal Fillers and Botulinum Toxin Market Drivers

1.5.2 Dermal Fillers and Botulinum Toxin Market Restraints

1.5.3 Dermal Fillers and Botulinum Toxin Industry Trends

1.5.4 Dermal Fillers and Botulinum Toxin Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Dermal Fillers and Botulinum Toxin Revenue by Company, 2018-2023

2.2 Global Dermal Fillers and Botulinum Toxin Sales Volume by Company, 2018-2023

2.3 Global Dermal Fillers and Botulinum Toxin Price by Company, 2018-2023

2.4 Global Dermal Fillers and Botulinum Toxin Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Dermal Fillers and Botulinum Toxin Concentration Ratio

2.6 Global Dermal Fillers and Botulinum Toxin Mergers & Acquisitions, Expansion Plans

2.7 Global Dermal Fillers and Botulinum Toxin Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Dermal Fillers and Botulinum Toxin Revenue by Company, 2018-2023

3.2 China Dermal Fillers and Botulinum Toxin Sales Volume by Company, 2018-2023

3.3 China Dermal Fillers and Botulinum Toxin Dermal Fillers and Botulinum Toxin Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Dermal Fillers and Botulinum Toxin Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)

3.5 Chinese Local Players, Dermal Fillers and Botulinum Toxin Domestic VS Export

3.6 China Market, Dermal Fillers and Botulinum Toxin Import & Export

3.6.1 China Market, Dermal Fillers and Botulinum Toxin Import & Export, 2018-2029

3.6.2 China Dermal Fillers and Botulinum Toxin Import & Export Trends

3.6.3 Main Sources of China Dermal Fillers and Botulinum Toxin Import

3.6.4 Export Destination of China Dermal Fillers and Botulinum Toxin

4 Dermal Fillers and Botulinum Toxin Production by Region

4.1 Global Dermal Fillers and Botulinum Toxin Capacity, Production and Capacity Utilization, 2018-2029

4.2 Global Geographic Distribution of Dermal Fillers and Botulinum Toxin Manufacturers

4.3 Global Major Manufacturers, Dermal Fillers and Botulinum Toxin Capacity Expansion and Future Plans

4.4 Global Dermal Fillers and Botulinum Toxin Capacity by Region

4.5 Global Dermal Fillers and Botulinum Toxin Production by Region

4.5.1 Global Dermal Fillers and Botulinum Toxin Production & Forecast by Region, 2018 VS 2022 VS 2029

4.5.2 Global Dermal Fillers and Botulinum Toxin Production by Region, 2018-2023

4.5.3 Global Dermal Fillers and Botulinum Toxin Production Market Share & Forecast by Region, 2018-2029

5 Industry Chain Analysis

5.1 Dermal Fillers and Botulinum Toxin Industry Chain

5.2 Dermal Fillers and Botulinum Toxin Upstream Analysis

5.2.1 Dermal Fillers and Botulinum Toxin Core Raw Materials

5.2.2 Main Manufacturers of Dermal Fillers and Botulinum Toxin Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Dermal Fillers and Botulinum Toxin Production Mode

5.6 Dermal Fillers and Botulinum Toxin Procurement Model

5.7 Dermal Fillers and Botulinum Toxin Industry Sales Model and Sales Channels

5.7.1 Dermal Fillers and Botulinum Toxin Sales Model

5.7.2 Dermal Fillers and Botulinum Toxin Typical Distributors

6 Sights by Type

6.1 Dermal Fillers and Botulinum Toxin Classification

6.1.1 Dermal Fillers

6.1.2 Botulinum Toxin

6.2 By Type, Global Dermal Fillers and Botulinum Toxin Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Type, Global Dermal Fillers and Botulinum Toxin Revenue, 2018-2029

6.4 By Type, Global Dermal Fillers and Botulinum Toxin Sales Volume, 2018-2029

6.5 By Type, Global Dermal Fillers and Botulinum Toxin Price, 2018-2029

7 Sights by Application

7.1 Dermal Fillers and Botulinum Toxin Segment by Application

7.1.1 Cosmetic

7.1.2 Medical

7.2 By Application, Global Dermal Fillers and Botulinum Toxin Market Size & CAGR, 2018 VS 2022 VS 2029

7.3 By Application, Global Dermal Fillers and Botulinum Toxin Revenue, 2018-2029

7.4 By Application, Global Dermal Fillers and Botulinum Toxin Sales Volume, 2018-2029

7.5 By Application, Global Dermal Fillers and Botulinum Toxin Price, 2018-2029

8 Sales Sights by Region

8.1 By Region, Global Dermal Fillers and Botulinum Toxin Market Size, 2018 VS 2022 VS 2029

8.2 By Region, Global Dermal Fillers and Botulinum Toxin Revenue, 2018-2029

8.3 By Region, Global Dermal Fillers and Botulinum Toxin Sales Volume, 2018-2029

8.4 North America

8.4.1 North America Dermal Fillers and Botulinum Toxin Market Size & Forecasts, 2018-2029

8.4.2 By Country, North America Dermal Fillers and Botulinum Toxin Market Size Market Share

8.5 Europe

8.5.1 Europe Dermal Fillers and Botulinum Toxin Market Size & Forecasts, 2018-2029

8.5.2 By Country, Europe Dermal Fillers and Botulinum Toxin Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Dermal Fillers and Botulinum Toxin Market Size & Forecasts, 2018-2029

8.6.2 By Country/Region, Asia Pacific Dermal Fillers and Botulinum Toxin Market Size Market Share

8.7 South America

8.7.1 South America Dermal Fillers and Botulinum Toxin Market Size & Forecasts, 2018-2029

8.7.2 By Country, South America Dermal Fillers and Botulinum Toxin Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Dermal Fillers and Botulinum Toxin Market Size & CAGR，2018 VS 2022 VS 2029

9.2 By Country, Global Dermal Fillers and Botulinum Toxin Revenue, 2018-2029

9.3 By Country, Global Dermal Fillers and Botulinum Toxin Sales Volume, 2018-2029

9.4 U.S.

9.4.1 U.S. Dermal Fillers and Botulinum Toxin Market Size, 2018-2029

9.4.2 By Company, U.S. Dermal Fillers and Botulinum Toxin Sales Volume Market Share, 2022

9.4.3 By Type, U.S. Dermal Fillers and Botulinum Toxin Market Size, Share, 2022 VS 2029

9.4.4 By Application, U.S. Dermal Fillers and Botulinum Toxin Market Size, Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe Dermal Fillers and Botulinum Toxin Market Size, 2018-2029

9.5.2 By Company, Europe Dermal Fillers and Botulinum Toxin Sales Volume Market Share, 2022

9.5.3 By Type, Europe Dermal Fillers and Botulinum Toxin Market Size, Share, 2022 VS 2029

9.5.4 By Application, Europe Dermal Fillers and Botulinum Toxin Market Size, Share, 2022 VS 2029

9.6 China

9.6.1 China Dermal Fillers and Botulinum Toxin Market Size, 2018-2029

9.6.2 By Company, China Dermal Fillers and Botulinum Toxin Sales Volume Market Share, 2022

9.6.3 By Type, China Dermal Fillers and Botulinum Toxin Market Size, Share, 2022 VS 2029

9.6.4 By Application, China Dermal Fillers and Botulinum Toxin Market Size, Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan Dermal Fillers and Botulinum Toxin Market Size, 2018-2029

9.7.2 By Company, Japan Dermal Fillers and Botulinum Toxin Sales Volume Market Share, 2022

9.7.3 By Type, Japan Dermal Fillers and Botulinum Toxin Market Size, Share, 2022 VS 2029

9.7.4 By Application, Japan Dermal Fillers and Botulinum Toxin Market Size, Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea Dermal Fillers and Botulinum Toxin Market Size, 2018-2029

9.8.2 By Company, South Korea Dermal Fillers and Botulinum Toxin Sales Volume Market Share, 2022

9.8.3 By Type, South Korea Dermal Fillers and Botulinum Toxin Market Size, Share, 2022 VS 2029

9.8.4 By Application, South Korea Dermal Fillers and Botulinum Toxin Market Size, Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia Dermal Fillers and Botulinum Toxin Market Size, 2018-2029

9.9.2 By Company, Southeast Asia Dermal Fillers and Botulinum Toxin Sales Volume Market Share, 2022

9.9.3 By Type, Southeast Asia Dermal Fillers and Botulinum Toxin Market Size, Share, 2022 VS 2029

9.9.4 By Application, Southeast Asia Dermal Fillers and Botulinum Toxin Market Size, Share, 2022 VS 2029

9.10 India

9.10.1 India Dermal Fillers and Botulinum Toxin Market Size, 2018-2029

9.10.2 By Company, India Dermal Fillers and Botulinum Toxin Sales Volume Market Share, 2022

9.10.3 By Type, India Dermal Fillers and Botulinum Toxin Market Size, Share, 2022 VS 2029

9.10.4 By Application, India Dermal Fillers and Botulinum Toxin Market Size, Share, 2022 VS 2029

9.11 Middle East & Asia

9.11.1 Middle East & Asia Dermal Fillers and Botulinum Toxin Market Size, 2018-2029

9.11.2 By Company, Middle East & Asia Dermal Fillers and Botulinum Toxin Sales Volume Market Share, 2022

9.11.3 By Type, Middle East & Asia Dermal Fillers and Botulinum Toxin Market Size, Share, 2022 VS 2029

9.11.4 By Application, Middle East & Asia Dermal Fillers and Botulinum Toxin Market Size, Share, 2022 VS 2029

10 Manufacturers Profile

10.1 AbbVie

10.1.1 AbbVie Company Information, Head Office, Market Area and Industry Position

10.1.2 AbbVie Dermal Fillers and Botulinum Toxin Models, Specifications and Application

10.1.3 AbbVie Dermal Fillers and Botulinum Toxin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.1.4 AbbVie Company Profile and Main Business

10.1.5 AbbVie Recent Developments

10.2 Galderma

10.2.1 Galderma Company Information, Head Office, Market Area and Industry Position

10.2.2 Galderma Dermal Fillers and Botulinum Toxin Models, Specifications and Application

10.2.3 Galderma Dermal Fillers and Botulinum Toxin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.2.4 Galderma Company Profile and Main Business

10.2.5 Galderma Recent Developments

10.3 LG Life Sciences

10.3.1 LG Life Sciences Company Information, Head Office, Market Area and Industry Position

10.3.2 LG Life Sciences Dermal Fillers and Botulinum Toxin Models, Specifications and Application

10.3.3 LG Life Sciences Dermal Fillers and Botulinum Toxin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.3.4 LG Life Sciences Company Profile and Main Business

10.3.5 LG Life Sciences Recent Developments

10.4 Merz

10.4.1 Merz Company Information, Head Office, Market Area and Industry Position

10.4.2 Merz Dermal Fillers and Botulinum Toxin Models, Specifications and Application

10.4.3 Merz Dermal Fillers and Botulinum Toxin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.4.4 Merz Company Profile and Main Business

10.4.5 Merz Recent Developments

10.5 Medytox

10.5.1 Medytox Company Information, Head Office, Market Area and Industry Position

10.5.2 Medytox Dermal Fillers and Botulinum Toxin Models, Specifications and Application

10.5.3 Medytox Dermal Fillers and Botulinum Toxin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.5.4 Medytox Company Profile and Main Business

10.5.5 Medytox Recent Developments

10.6 Hugel

10.6.1 Hugel Company Information, Head Office, Market Area and Industry Position

10.6.2 Hugel Dermal Fillers and Botulinum Toxin Models, Specifications and Application

10.6.3 Hugel Dermal Fillers and Botulinum Toxin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.6.4 Hugel Company Profile and Main Business

10.6.5 Hugel Recent Developments

10.7 Croma-Pharma

10.7.1 Croma-Pharma Company Information, Head Office, Market Area and Industry Position

10.7.2 Croma-Pharma Dermal Fillers and Botulinum Toxin Models, Specifications and Application

10.7.3 Croma-Pharma Dermal Fillers and Botulinum Toxin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.7.4 Croma-Pharma Company Profile and Main Business

10.7.5 Croma-Pharma Recent Developments

10.8 Beijing IMEIK

10.8.1 Beijing IMEIK Company Information, Head Office, Market Area and Industry Position

10.8.2 Beijing IMEIK Dermal Fillers and Botulinum Toxin Models, Specifications and Application

10.8.3 Beijing IMEIK Dermal Fillers and Botulinum Toxin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.8.4 Beijing IMEIK Company Profile and Main Business

10.8.5 Beijing IMEIK Recent Developments

10.9 Bloomage Bio

10.9.1 Bloomage Bio Company Information, Head Office, Market Area and Industry Position

10.9.2 Bloomage Bio Dermal Fillers and Botulinum Toxin Models, Specifications and Application

10.9.3 Bloomage Bio Dermal Fillers and Botulinum Toxin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.9.4 Bloomage Bio Company Profile and Main Business

10.9.5 Bloomage Bio Recent Developments

10.10 Elravie (Humedix)

10.10.1 Elravie (Humedix) Company Information, Head Office, Market Area and Industry Position

10.10.2 Elravie (Humedix) Dermal Fillers and Botulinum Toxin Models, Specifications and Application

10.10.3 Elravie (Humedix) Dermal Fillers and Botulinum Toxin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.10.4 Elravie (Humedix) Company Profile and Main Business

10.10.5 Elravie (Humedix) Recent Developments

10.11 Cleviel (Pharma Research Products)

10.11.1 Cleviel (Pharma Research Products) Company Information, Head Office, Market Area and Industry Position

10.11.2 Cleviel (Pharma Research Products) Dermal Fillers and Botulinum Toxin Models, Specifications and Application

10.11.3 Cleviel (Pharma Research Products) Dermal Fillers and Botulinum Toxin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.11.4 Cleviel (Pharma Research Products) Company Profile and Main Business

10.11.5 Cleviel (Pharma Research Products) Recent Developments

10.12 Haohai Biological

10.12.1 Haohai Biological Company Information, Head Office, Market Area and Industry Position

10.12.2 Haohai Biological Dermal Fillers and Botulinum Toxin Models, Specifications and Application

10.12.3 Haohai Biological Dermal Fillers and Botulinum Toxin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.12.4 Haohai Biological Company Profile and Main Business

10.12.5 Haohai Biological Recent Developments

10.13 Teoxane

10.13.1 Teoxane Company Information, Head Office, Market Area and Industry Position

10.13.2 Teoxane Dermal Fillers and Botulinum Toxin Models, Specifications and Application

10.13.3 Teoxane Dermal Fillers and Botulinum Toxin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.13.4 Teoxane Company Profile and Main Business

10.13.5 Teoxane Recent Developments

10.14 Sinclair

10.14.1 Sinclair Company Information, Head Office, Market Area and Industry Position

10.14.2 Sinclair Dermal Fillers and Botulinum Toxin Models, Specifications and Application

10.14.3 Sinclair Dermal Fillers and Botulinum Toxin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.14.4 Sinclair Company Profile and Main Business

10.14.5 Sinclair Recent Developments

10.15 Suneva Medical

10.15.1 Suneva Medical Company Information, Head Office, Market Area and Industry Position

10.15.2 Suneva Medical Dermal Fillers and Botulinum Toxin Models, Specifications and Application

10.15.3 Suneva Medical Dermal Fillers and Botulinum Toxin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.15.4 Suneva Medical Company Profile and Main Business

10.15.5 Suneva Medical Recent Developments

10.16 CG Bio

10.16.1 CG Bio Company Information, Head Office, Market Area and Industry Position

10.16.2 CG Bio Dermal Fillers and Botulinum Toxin Models, Specifications and Application

10.16.3 CG Bio Dermal Fillers and Botulinum Toxin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.16.4 CG Bio Company Profile and Main Business

10.16.5 CG Bio Recent Developments

10.17 SciVision Biotech

10.17.1 SciVision Biotech Company Information, Head Office, Market Area and Industry Position

10.17.2 SciVision Biotech Dermal Fillers and Botulinum Toxin Models, Specifications and Application

10.17.3 SciVision Biotech Dermal Fillers and Botulinum Toxin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.17.4 SciVision Biotech Company Profile and Main Business

10.17.5 SciVision Biotech Recent Developments

10.18 Prollenium

10.18.1 Prollenium Company Information, Head Office, Market Area and Industry Position

10.18.2 Prollenium Dermal Fillers and Botulinum Toxin Models, Specifications and Application

10.18.3 Prollenium Dermal Fillers and Botulinum Toxin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.18.4 Prollenium Company Profile and Main Business

10.18.5 Prollenium Recent Developments

10.19 Bohus BioTech

10.19.1 Bohus BioTech Company Information, Head Office, Market Area and Industry Position

10.19.2 Bohus BioTech Dermal Fillers and Botulinum Toxin Models, Specifications and Application

10.19.3 Bohus BioTech Dermal Fillers and Botulinum Toxin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.19.4 Bohus BioTech Company Profile and Main Business

10.19.5 Bohus BioTech Recent Developments

10.20 Caregen

10.20.1 Caregen Company Information, Head Office, Market Area and Industry Position

10.20.2 Caregen Dermal Fillers and Botulinum Toxin Models, Specifications and Application

10.20.3 Caregen Dermal Fillers and Botulinum Toxin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.20.4 Caregen Company Profile and Main Business

10.20.5 Caregen Recent Developments

10.21 Ipsen

10.21.1 Ipsen Company Information, Head Office, Market Area and Industry Position

10.21.2 Ipsen Dermal Fillers and Botulinum Toxin Models, Specifications and Application

10.21.3 Ipsen Dermal Fillers and Botulinum Toxin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.21.4 Ipsen Company Profile and Main Business

10.21.5 Ipsen Recent Developments

10.22 LIBP

10.22.1 LIBP Company Information, Head Office, Market Area and Industry Position

10.22.2 LIBP Dermal Fillers and Botulinum Toxin Models, Specifications and Application

10.22.3 LIBP Dermal Fillers and Botulinum Toxin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.22.4 LIBP Company Profile and Main Business

10.22.5 LIBP Recent Developments

10.23 US World Meds

10.23.1 US World Meds Company Information, Head Office, Market Area and Industry Position

10.23.2 US World Meds Dermal Fillers and Botulinum Toxin Models, Specifications and Application

10.23.3 US World Meds Dermal Fillers and Botulinum Toxin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.23.4 US World Meds Company Profile and Main Business

10.23.5 US World Meds Recent Developments

10.24 Daewoong

10.24.1 Daewoong Company Information, Head Office, Market Area and Industry Position

10.24.2 Daewoong Dermal Fillers and Botulinum Toxin Models, Specifications and Application

10.24.3 Daewoong Dermal Fillers and Botulinum Toxin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.24.4 Daewoong Company Profile and Main Business

10.24.5 Daewoong Recent Developments

10.25 JETEMA

10.25.1 JETEMA Company Information, Head Office, Market Area and Industry Position

10.25.2 JETEMA Dermal Fillers and Botulinum Toxin Models, Specifications and Application

10.25.3 JETEMA Dermal Fillers and Botulinum Toxin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.25.4 JETEMA Company Profile and Main Business

10.25.5 JETEMA Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Dermal Fillers and Botulinum Toxin Market Size & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Dermal Fillers and Botulinum Toxin Market Restraints

Table 3. Dermal Fillers and Botulinum Toxin Market Trends

Table 4. Dermal Fillers and Botulinum Toxin Industry Policy

Table 5. Global Dermal Fillers and Botulinum Toxin Revenue by Company, 2018-2023, US$ million

Table 6. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Company, 2018-2023

Table 7. Global Dermal Fillers and Botulinum Toxin Sales Volume by Company, 2018-2023, (K Units)

Table 8. Global Dermal Fillers and Botulinum Toxin Sales Volume Market Share by Company, 2018-2023

Table 9. Global Dermal Fillers and Botulinum Toxin Price by Company, 2018-2023, (USD/Unit)

Table 10. Global Dermal Fillers and Botulinum Toxin Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Dermal Fillers and Botulinum Toxin Mergers & Acquisitions, Expansion Plans

Table 12. Global Dermal Fillers and Botulinum Toxin Manufacturers Product Type

Table 13. China Dermal Fillers and Botulinum Toxin Revenue by Company, 2018-2023, US$ million

Table 14. China Dermal Fillers and Botulinum Toxin Revenue Market Share by Company, 2018-2023

Table 15. China Dermal Fillers and Botulinum Toxin Sales Volume by Company, 2018-2023, (K Units)

Table 16. China Dermal Fillers and Botulinum Toxin Sales Volume Market Share by Company, 2018-2023

Table 17. China Market, Dermal Fillers and Botulinum Toxin Production, Sales, Import and Export, 2018-2029, (K Units)

Table 18. China Dermal Fillers and Botulinum Toxin Import & Export Trends

Table 19. Main Sources of China Dermal Fillers and Botulinum Toxin Import

Table 20. Export Destination of China Dermal Fillers and Botulinum Toxin

Table 21. Global Headquarters and Manufacturing Base of Dermal Fillers and Botulinum Toxin Manufacturers

Table 22. Global Major Manufacturers, Dermal Fillers and Botulinum Toxin Capacity Expansion and Future Plans

Table 23. Global Dermal Fillers and Botulinum Toxin Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 24. Global Dermal Fillers and Botulinum Toxin Production by Region, 2018-2023, (K Units)

Table 25. Global Dermal Fillers and Botulinum Toxin Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of Dermal Fillers and Botulinum Toxin Upstream (Raw Materials)

Table 27. Global Dermal Fillers and Botulinum Toxin Typical Customers

Table 28. Dermal Fillers and Botulinum Toxin Typical Distributors

Table 29. By Type, Global Dermal Fillers and Botulinum Toxin Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Application, Global Dermal Fillers and Botulinum Toxin Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 31. By Region, Global Dermal Fillers and Botulinum Toxin Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 32. By Region, Global Dermal Fillers and Botulinum Toxin Revenue, 2018-2029, US$ Million

Table 33. By Region, Global Dermal Fillers and Botulinum Toxin Sales Volume, 2018-2029, (K Units)

Table 34. By Country, Global Dermal Fillers and Botulinum Toxin Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 35. By Country, Global Dermal Fillers and Botulinum Toxin Revenue, 2018-2029, US$ Million

Table 36. By Country, Global Dermal Fillers and Botulinum Toxin Revenue Market Share, 2018-2029

Table 37. By Country, Global Dermal Fillers and Botulinum Toxin Sales Volume, 2018-2029, (K Units)

Table 38. By Country, Global Dermal Fillers and Botulinum Toxin Sales Volume Market Share, 2018-2029

Table 39. AbbVie Company Information, Head Office, Market Area and Industry Position

Table 40. AbbVie Dermal Fillers and Botulinum Toxin Models, Specifications and Application

Table 41. AbbVie Dermal Fillers and Botulinum Toxin Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023

Table 42. AbbVie Company Profile and Main Business

Table 43. AbbVie Recent Developments

Table 44. Galderma Company Information, Head Office, Market Area and Industry Position

Table 45. Galderma Dermal Fillers and Botulinum Toxin Models, Specifications and Application

Table 46. Galderma Dermal Fillers and Botulinum Toxin Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023

Table 47. Galderma Company Profile and Main Business

Table 48. Galderma Recent Developments

Table 49. LG Life Sciences Company Information, Head Office, Market Area and Industry Position

Table 50. LG Life Sciences Dermal Fillers and Botulinum Toxin Models, Specifications and Application

Table 51. LG Life Sciences Dermal Fillers and Botulinum Toxin Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023

Table 52. LG Life Sciences Company Profile and Main Business

Table 53. LG Life Sciences Recent Developments

Table 54. Merz Company Information, Head Office, Market Area and Industry Position

Table 55. Merz Dermal Fillers and Botulinum Toxin Models, Specifications and Application

Table 56. Merz Dermal Fillers and Botulinum Toxin Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023

Table 57. Merz Company Profile and Main Business

Table 58. Merz Recent Developments

Table 59. Medytox Company Information, Head Office, Market Area and Industry Position

Table 60. Medytox Dermal Fillers and Botulinum Toxin Models, Specifications and Application

Table 61. Medytox Dermal Fillers and Botulinum Toxin Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023

Table 62. Medytox Company Profile and Main Business

Table 63. Medytox Recent Developments

Table 64. Hugel Company Information, Head Office, Market Area and Industry Position

Table 65. Hugel Dermal Fillers and Botulinum Toxin Models, Specifications and Application

Table 66. Hugel Dermal Fillers and Botulinum Toxin Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023

Table 67. Hugel Company Profile and Main Business

Table 68. Hugel Recent Developments

Table 69. Croma-Pharma Company Information, Head Office, Market Area and Industry Position

Table 70. Croma-Pharma Dermal Fillers and Botulinum Toxin Models, Specifications and Application

Table 71. Croma-Pharma Dermal Fillers and Botulinum Toxin Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023

Table 72. Croma-Pharma Company Profile and Main Business

Table 73. Croma-Pharma Recent Developments

Table 74. Beijing IMEIK Company Information, Head Office, Market Area and Industry Position

Table 75. Beijing IMEIK Dermal Fillers and Botulinum Toxin Models, Specifications and Application

Table 76. Beijing IMEIK Dermal Fillers and Botulinum Toxin Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023

Table 77. Beijing IMEIK Company Profile and Main Business

Table 78. Beijing IMEIK Recent Developments

Table 79. Bloomage Bio Company Information, Head Office, Market Area and Industry Position

Table 80. Bloomage Bio Dermal Fillers and Botulinum Toxin Models, Specifications and Application

Table 81. Bloomage Bio Dermal Fillers and Botulinum Toxin Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023

Table 82. Bloomage Bio Company Profile and Main Business

Table 83. Bloomage Bio Recent Developments

Table 84. Elravie (Humedix) Company Information, Head Office, Market Area and Industry Position

Table 85. Elravie (Humedix) Dermal Fillers and Botulinum Toxin Models, Specifications and Application

Table 86. Elravie (Humedix) Dermal Fillers and Botulinum Toxin Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023

Table 87. Elravie (Humedix) Company Profile and Main Business

Table 88. Elravie (Humedix) Recent Developments

Table 89. Cleviel (Pharma Research Products) Company Information, Head Office, Market Area and Industry Position

Table 90. Cleviel (Pharma Research Products) Dermal Fillers and Botulinum Toxin Models, Specifications and Application

Table 91. Cleviel (Pharma Research Products) Dermal Fillers and Botulinum Toxin Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023

Table 92. Cleviel (Pharma Research Products) Company Profile and Main Business

Table 93. Cleviel (Pharma Research Products) Recent Developments

Table 94. Haohai Biological Company Information, Head Office, Market Area and Industry Position

Table 95. Haohai Biological Dermal Fillers and Botulinum Toxin Models, Specifications and Application

Table 96. Haohai Biological Dermal Fillers and Botulinum Toxin Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023

Table 97. Haohai Biological Company Profile and Main Business

Table 98. Haohai Biological Recent Developments

Table 99. Teoxane Company Information, Head Office, Market Area and Industry Position

Table 100. Teoxane Dermal Fillers and Botulinum Toxin Models, Specifications and Application

Table 101. Teoxane Dermal Fillers and Botulinum Toxin Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023

Table 102. Teoxane Company Profile and Main Business

Table 103. Teoxane Recent Developments

Table 104. Sinclair Company Information, Head Office, Market Area and Industry Position

Table 105. Sinclair Dermal Fillers and Botulinum Toxin Models, Specifications and Application

Table 106. Sinclair Dermal Fillers and Botulinum Toxin Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023

Table 107. Sinclair Company Profile and Main Business

Table 108. Sinclair Recent Developments

Table 109. Suneva Medical Company Information, Head Office, Market Area and Industry Position

Table 110. Suneva Medical Dermal Fillers and Botulinum Toxin Models, Specifications and Application

Table 111. Suneva Medical Dermal Fillers and Botulinum Toxin Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023

Table 112. Suneva Medical Company Profile and Main Business

Table 113. Suneva Medical Recent Developments

Table 114. CG Bio Company Information, Head Office, Market Area and Industry Position

Table 115. CG Bio Dermal Fillers and Botulinum Toxin Models, Specif

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)